AI-driven treatment approach and growing Fragile X Syndrome market size Healx Pharma has recently partnered with Boehringer Ingelheim to advance the treatment market and invest in…
Category: Articles
Dec 9 
Are Rare diseases truly Rare?
Rare diseases, as the name depicts, affect only a small number of people compared to the other disease. Worldwide, one out of 15 persons could be…
Dec 6 
Hype over Gene Therapy: Challenges and Opportunities
Gene therapy is one of the hottest topics of biotechnology’s vertical in this century. Once considered incurable genetic disorders, now have a cure that is cent…
Dec 5 
Reblozyl under FDA review; Audentes buyout & Tecentriq’s new approval
Bristol-Meyers Squibb and Acceleron Pharma have announced that US FDA committee will review BMS’s supplemental Biologics License Application (sBLA) for its Reblozyl in MDS. Reblozyl ((luspatercept-aamt)…
Dec 4 
The Regulatory process for drug approval in the MENA region
The MENA (the Middle East and North Africa) region is mostly an untouched market, which is an impetus for potential development and lucrative growth in the…
Dec 2 
Chronic Refractory Cough Market landscape: A new approach to treating cough
When cough seems everlasting, mortifying, and excruciating, it is high time to consult a physician as you might be stricken by chronic cough, which can be…
Nov 29 
Alzheimer’s Disease Market Infographic
It’s is the end of Alzheimer’s Awareness Month, but our hope for a cure for this disease will not end. They may not remember us, but…
Nov 29 
UREA CYCLE DISORDER – A LOST ENZYME may lead to FATAL RISKS
Do you feel sleepy or fussy? Do you suffer from seizures or breathing problem? And your body temperature is mostly low?You should get it checked, as…
Nov 25 
How Gene therapy is changing the Beta-thalassemia Treatment outlook?
Beta thalassemia, globally affects almost 288,000 people, with an incidence of 60,000 cases every year. A rare monogenic genetic disease, beta-thalassemia is caused by more than…
Nov 22 
The long journey of Biosimilars: Is it an emerging opportunity?
Biologics are not new drugs, their use as a medicine has been around for over a century. The first use of Biologic drug dates back to…
